Company news
Tela Bio, Inc. (NASDAQ:TELA) news
Every Tela Bio, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
TELA Bio Announces COO / CFO Transition and Strategic Cost Reduction Initiative
August 31, 2026
TELA Bio Reports Second Quarter 2026 Financial Results
August 10, 2026
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)
August 6, 2026
TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director
August 4, 2026
TELA Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference
July 29, 2026
TELA Bio to Announce Second Quarter 2026 Financial Results
July 20, 2026
TELA Bio Reports First Quarter 2026 Financial Results
May 12, 2026
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Pro...
April 30, 2026
TELA Bio to Announce First Quarter 2026 Financial Results
April 21, 2026
TELA Bio Reports Fourth Quarter and Full Year 2025 Financial Results
March 24, 2026
TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results
March 10, 2026
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 23, 2026
TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference
November 19, 2025
TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants
November 13, 2025
TELA Bio Reports Third Quarter 2025 Financial Results and Refinancing and Upsizing of Credit Facility
November 13, 2025
TELA Bio to Announce Third Quarter 2025 Financial Results
November 4, 2025
TELA Bio Appoints William Plovanic to Board of Directors
November 3, 2025
TELA Bio Announces Addition of Betty Jo Rocchio to Board of Directors and the Departure of Director Lisa Colleran
October 9, 2025
TELA Bio Reports Second Quarter 2025 Financial Results
August 11, 2025
TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference
July 23, 2025
TELA Bio to Announce Second Quarter 2025 Financial Results
July 21, 2025
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
June 6, 2025
TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair
June 3, 2025
TELA Bio Appoints Jeffrey Blizard as President
June 2, 2025
TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference
May 22, 2025
TELA Bio Reports First Quarter 2025 Financial Results
May 8, 2025
TELA Bio to Announce First Quarter 2025 Financial Results
April 17, 2025
TELA Bio Announces U.S. Commercial Launch of Larger Sizes of OviTex® PRS for Plastic and Reconstructive Surgery
March 31, 2025
TELA Bio Reports Fourth Quarter and Full Year 2024 Financial Results
March 20, 2025
TELA Bio to Announce Fourth Quarter and Full Year 2024 Financial Results
February 27, 2025
TELA Bio to Participate in Piper Sandler’s 36th Annual Healthcare Conference
November 19, 2024
TELA Bio Reports Third Quarter 2024 Financial Results
November 7, 2024
TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Pu...
October 24, 2024
TELA Bio Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
October 23, 2024
TELA Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
October 22, 2024
TELA Bio to Announce Third Quarter 2024 Financial Results
October 17, 2024
TELA Bio Reports Second Quarter 2024 Financial Results and Reiterates Full Year 2024 Revenue Guidance
August 12, 2024
TELA Bio to Participate in the Canaccord Genuity 44th Annual Growth Conference
July 25, 2024
TELA Bio to Announce Second Quarter 2024 Financial Results
July 22, 2024
TELA Bio Appoints Jeffrey Blizard to its Board of Directors
June 4, 2024
TELA Bio Appoints Greg Firestone as Chief Commercial Officer
May 20, 2024
TELA Bio Reports First Quarter 2024 Financial Results
May 9, 2024
TELA Bio to Announce First Quarter 2024 Financial Results
April 25, 2024
TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal H...
April 15, 2024
TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy
April 8, 2024
TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery
March 21, 2024
TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Results
March 21, 2024
TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX
March 20, 2024
MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing
March 20, 2024
TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results
February 29, 2024